Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3612.9000 33.80 (0.94%)
NSE Sep 08, 2025 15:47 PM
Volume: 166.1K
 

3612.90
0.94%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 16% YoY to | 1429 crore (I-direct estimate: | 1583 crore) mainly due to 55% YoY de-growth in the US to | 322 crore (I-direct estimate: | 443 crore). The decline in US sales was due to the high base of gAbilify exclusivity in Q2FY16. Domestic revenue grew 13% YoY at | 496 crore (I-direct estimate: | 479 crore) EBITDA margins declined to 23.1% (I-direct estimate: 30.0%) vs....
Torrent Pharmaceutic.. has an average target of 3746.00 from 5 brokers.
More from Torrent Pharmaceuticals Ltd.
Recommended